Clover Health Investments, Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2024 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q1 2025 | 1 | -$0.05 | -$0.04 | -$0.04 |
| Q2 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q1 2026 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
Clover Health Investments, Corp. Earnings Date And Information
Clover Health Investments, Corp. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.02 earnings per share for the quarter, missing analysts' consensus estimates of $-0.01333 by $0.00667. The company had revenue of 330.99 M for the quarter and had revenue of 2.03 B for the year. Clover Health Investments, Corp. has generated $0 earnings per share over the last year ($-0.44 diluted earnings per share) and currently has a price-to-earnings ratio of -18.02. Clover Health Investments, Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Clover Health Investments, Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$0.02 | $346.28 M | $330.99 M | ||
| 08/08/2024 | Q2 2024 | $0.02 | $338.76 M | $356.24 M | ||
| 05/07/2024 | Q1 2024 | -$0.07 | -$0.04 | 0.03 | $346.46 M | |
| 03/14/2024 | Q4 2023 | -$0.15 | $505.44 M | |||
| 11/06/2023 | Q3 2023 | -$0.10 | -$0.09 | 0.01 | $494.59 M | $482.07 M |
| 08/08/2023 | Q2 2023 | -$0.13 | -$0.06 | 0.07 | $490.82 M | $513.63 M |
| 05/09/2023 | Q1 2023 | -$0.19 | -$0.15 | 0.04 | $527.78 M | |
| 03/01/2023 | Q4 2022 | -$0.13 | $898.79 M | |||
| 11/07/2022 | Q3 2022 | -$0.31 | -$0.16 | 0.15 | $799.47 M | $856.82 M |
| 08/08/2022 | Q2 2022 | -$0.23 | -$0.22 | 0.01 | $814.61 M | $846.70 M |
| 05/09/2022 | Q1 2022 | -$0.24 | -$0.13 | 0.11 | $874.38 M | |
| 02/28/2022 | Q4 2021 | -$0.26 | -$0.40 | -0.14 | $432.04 M | |
| 11/09/2021 | Q3 2021 | -$0.31 | -$0.08 | 0.23 | $413.10 M | $427.16 M |
| 08/11/2021 | Q2 2021 | -$0.17 | -$0.78 | -0.61 | $205.39 M | $412.47 M |
| 05/17/2021 | Q1 2021 | -$0.12 | -$0.13 | -0.01 | $200.33 M | |
| 03/31/2021 | Q4 2020 | -$0.20 | $166.23 M | |||
| 11/13/2020 | Q3 2020 | $0.03 | $169.07 M | |||
| 08/13/2020 | Q2 2020 | $0.01 | $172.08 M | |||
| 06/04/2020 | Q1 2020 | -$0.07 | $165.51 M | |||
| 12/30/2019 | Q4 2019 | $0.00 | $100.55 M |
Clover Health Investments, Corp. Earnings: Frequently Asked Questions
-
When is Clover Health Investments, Corp.'s earnings date?
Clover Health Investments, Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
-
How can I listen to Clover Health Investments, Corp.'s earnings conference call?
The conference call for Clover Health Investments, Corp.'s latest earnings report can be listened to online.
-
How can I read Clover Health Investments, Corp.'s conference call transcript?
The conference call transcript for Clover Health Investments, Corp.'s latest earnings report can be read online.
-
How much revenue does Clover Health Investments, Corp. generate each year?
Clover Health Investments, Corp. (:CLOV) has a recorded annual revenue of $2.03 B.
-
How much profit does Clover Health Investments, Corp. generate each year?
Clover Health Investments, Corp. (:CLOV) has a recorded net income of $2.03 B. Clover Health Investments, Corp. has generated $-0.44 earnings per share over the last four quarters.
-
What is Clover Health Investments, Corp.'s price-to-earnings ratio?
Clover Health Investments, Corp. (:CLOV) has a price-to-earnings ratio of -18.02 and price/earnings-to-growth ratio is -0.67.
